Big Pharma Buy Incites U.S. Stocks to Rise
Big Pharma Buy Incites U.S. Stocks to Rise
Valeant Pharmaceuticals International Inc. Offers to Buy Botox Giant Allergan Inc.
Valeant Pharmaceuticals International Inc. Offers to Buy Botox Giant A...
U.S. Stocks Advance
U.S. Stocks Advance
Hedge Funds Lowered Bullish Bets on Gold
Hedge Funds Lowered Bullish Bets on Gold
Job Listings

Eli Lilly Settling Bribe Case for $29 Million

On Thursday, U.S. pharmaceutical company Eli Lilly and Co agreed to pay a sum of $29 million to settle civil charges by SEC alleging that the company’s subsidiaries had made improper payments to foreign government officials to get business in, Brazil, China Poland and Russia. Lilly’s settlement is part of a broader investigation into the U.S. pharmaceutical industry by authorities.

 

The present settlement is in respect of the outcomes of an investigation by the SEC made into activities of Eli Lilly spanning from 1994 to 2009. The company said that it was first notified of the probe in 2003. In the instant case, SEC had alleged that a Russian unit of the company had been using instruments termed as ‘marketing agreements’ to channel millions of dollars through offshore companies to foreign government officials.

 

Eli Lilly agreed to the settlement without admitting or denying the charges. The company issued a statement saying that in addition to paying the settlement amount the company has also agreed to have an independent compliance consultant conduct a review of its FCPA compliance.



Get JD Journal in Your Mail
Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!


 

Kara Novaco Brockmeyer, head of the SEC enforcement unit specializing in FCPA said that “Companies can’t simply rely on paper thin assurances by employees, distributors, or customers. They need to look at the surrounding circumstances of any payment to adequately assess whether it could wind up in a government official’s pocket.” “Eli Lilly and its subsidiaries,” said Brockmeyer, “possessed a ‘check the box’ mentality when it came to third-party due diligence.”

 

Under the Foreign Corrupt Practices Act (FCPA) U.S. companies and foreign firms with listed U.S. stock are prohibited from bribing government officials to seek business. Speed-money, however, or expenses to speed up processes, and spent legally, is generally not covered by the act.

Did you like this? Share it:
Eli Lilly Settling Bribe Case for $29 Million by

Tagged: , , ,

Posted by on December 21, 2012. Filed under Business News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.
  • http://www.zyprexa-victims.com Daniel Haszard

    Lilly criminal on Zyprexa

    Eli Lilly is reaping what they have sown!
    The Lilly Zyprexa saga will go on and on and on….

    Eli Lilly has made $66 billion on Zyprexa and it was way oversold and caused diabetes and in some cases sudden death.
    Lilly’s (NOW up to $4.6 billion) Zyprexa setllement payout is being stonewalled. Eight Lilly employees who are supposed ‘whistleblowers’ are getting $ 10 million each the real victims like me are being ignored.

    I am a living example of Zyprexa gone/done wrong was given it 1996-2000 off-label for PTSD got sudden high blood sugar A1C 14.7 in January 2000.The stuff was worthless for my condition PTSD and cost me thousands in co-pays gave me diabetes.

    Daniel Haszard http://www.zyprexa-victims.com